News + Filings Transactions Holdings
|
RA CAPITAL MANAGEMENT, L.P.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Vaxcyte, Inc.
| PCVX | Common | 0 | -5,857,459 | 0 | -280,865,159,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | SPONSORED ADS | 0 | -6,317,990 | 0 | -165,089,079,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Legend Biotech Corp
| LEGN | SPONSORED ADS | 0 | -2,436,223 | 0 | -121,616,252,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
BELLUS Health Inc.
| BLU | Common | 0 | -12,452,574 | 0 | -102,360,158,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Celldex Therapeutics, Inc.
| CLDX | COMMON | 0 | -2,075,000 | 0 | -92,482,750,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Travere Therapeutics, Inc.
| TVTX | Common | 0 | -3,984,681 | 0 | -83,797,841,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | COM | 0 | -4,398,453 | 0 | -69,275,635,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Akero Therapeutics, Inc.
| AKRO | Common | 0 | -958,980 | 0 | -52,552,104,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
ROCKET PHARMACEUTICALS, INC.
| RCKT | Common | 0 | -2,407,149 | 0 | -47,107,906,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
HilleVax, Inc.
| HLVX | Common | 0 | -1,760,019 | 0 | -29,445,118,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Kinnate Biopharma Inc.
| KNTE | Common | 0 | -4,264,144 | 0 | -26,011,278,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | SPONSORED ADS | 0 | -880,000 | 0 | -25,704,800,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
DA32 Life Science Tech Acquisition Corp.
| DALS | Common | 0 | -1,500,000 | 0 | -14,992,500,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
scPharmaceuticals Inc.
| SCPH | Common | 0 | -1,856,904 | 0 | -13,314,002,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Enliven Therapeutics, Inc.
| IMRA | Common | 0 | -3,250,724 | 0 | -13,295,461,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
ARYA Sciences Acquisition Corp V
| ARYE | Common | 0 | -1,000,000 | 0 | -10,090,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Aadi Bioscience, Inc.
| AADI | Common | 0 | -590,218 | 0 | -7,572,497,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
CONCERT PHARMACEUTICALS, INC.
| CNCE | COM | 0 | -1,088,296 | 0 | -6,355,649,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Orchestra BioMed Holdings, Inc.
| HSAQ | ORD SHS | 0 | -610,283 | 0 | -6,090,624,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Athira Pharma, Inc.
| ATHA | Common | 0 | -1,881,300 | 0 | -5,963,721,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Satsuma Pharmaceuticals, Inc.
| STSA | Common | 0 | -5,914,252 | 0 | -5,322,827,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
CVRx, Inc.
| CVRX | COM | 0 | -275,000 | 0 | -5,046,250,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
DBV Technologies S.A.
| DBVT | SPONSORED ADR | 0 | -1,958,957 | 0 | -2,997,204,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
IO Biotech, Inc.
| IOBT | Common | 0 | -1,127,260 | 0 | -2,592,698,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Third Harmonic Bio, Inc.
| THRD | Common | 0 | -534,687 | 0 | -2,299,154,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Fusion Pharmaceuticals Inc.
| FUSN | Common | 0 | -659,992 | 0 | -2,078,975,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Achilles Therapeutics plc
| ACHL | SPONSORED ADS | 0 | -1,607,834 | 0 | -1,447,051,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
IMMUNIC, INC.
| IMUX | Common | 0 | -632,184 | 0 | -885,058,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Entera Bio Ltd.
| ENTX | SHS | 0 | -295,966 | 0 | -216,055,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|